Ruxolitinib is a selective Janus kinase (JAK1 and JAK2) inhibitor used in the treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease. This category features a comprehensive range… Read more


![Chemical structure of (3R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-(3-hydroxycyclopentyl)propanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1809535-63-4-3R-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-3-3-hydroxycyclopentylpropanenitrile.png&w=3840&q=75)
![Chemical structure of (3R)-3-Cyclopentyl-3-(4-(6-hydroxy-5-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3029006-62-7-3R-3-Cyclopentyl-3-4-6-hydroxy-5-oxo-67-dihydro-5H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanenitrile.png&w=3840&q=75)
![Chemical structure of (4-(1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1236033-05-8-4-1-2-Cyano-1-cyclopentylethyl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidin-7-ylmethyl-pivalate.png&w=3840&q=75)
![Chemical structure of (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl Pivalate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1146629-75-5-4-Chloro-7H-pyrrolo23-dpyrimidin-7-ylmethyl-Pivalate.png&w=3840&q=75)
![Chemical structure of (E)-2-(7-((Benzyloxy)carbonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-(dimethyliminio)-N,N-dimethylprop-1-en-1-aminium 2,2,2-Trifluoroacetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FE-2-7-Benzyloxycarbonyl-7H-pyrrolo23-dpyrimidin-4-yl-3-dimethyliminio-NN-dimethylprop-1-en-1-aminium-222-Trifluoroacetate.png&w=3840&q=75)
![Chemical structure of (R)-(4-(1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl Pivalate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1146629-80-2-R-4-1-2-Cyano-1-cyclopentylethyl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidin-7-ylmethyl-Pivalate.png&w=3840&q=75)
![Chemical structure of (R)-1-((R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoyl)-5-cyclopentylpyrazolidin-3-one compound with Dicyclohexylamine (1:1)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-1-R-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-3-cyclopentylpropanoyl-5-cyclopentylpyrazolidin-3-one-compound-with-Dicyclohexylamine-11.png&w=3840&q=75)
![Chemical structure of (R)-3-(4-(1-Benzyl-1H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-4-1-Benzyl-1H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-3-cyclopentylpropanenitrile.png&w=3840&q=75)


![Chemical structure of (R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2102675-42-1-R-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-3-cyclopentylpropanamide.png&w=3840&q=75)
![Chemical structure of (R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2102675-40-9-R-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-3-cyclopentylpropanoic-Acid.png&w=3840&q=75)


![Chemical structure of (R)-3-Cyclopentyl-3-(4-(2-(dimethylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-4-2-dimethylamino-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanoic-Acid.png&w=3840&q=75)

![Chemical structure of (R)-3-Cyclopentyl-3-(4-(5-((dimethylamino)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-4-5-dimethylaminomethyl-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanoic-Acid.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(4-(5-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-4-5-hydroxymethyl-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanenitrile.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F941685-40-1-R-3-Cyclopentyl-3-4-7-2-trimethylsilylethoxymethyl-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanenitrile.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile (2S,3S)-2,3-bis(benzoyloxy)succinate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1236033-04-7-R-3-Cyclopentyl-3-4-7-2-trimethylsilylethoxymethyl-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanenitrile-2S3S-23-bisbenzoyloxysuccin.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-4-7-nitroso-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanamide.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-4-7-nitroso-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanenitrile.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(4-(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-4-7-nitroso-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanoic-Acid.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(5-(dimethylamino)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-5-dimethylamino-4-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanamide.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(5-(dimethylamino)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-5-dimethylamino-4-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanenitrile.png&w=3840&q=75)
![Chemical structure of (R)-3-Cyclopentyl-3-(5-(dimethylamino)-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-3-Cyclopentyl-3-5-dimethylamino-4-7H-pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-ylpropanoic-Acid.png&w=3840&q=75)

![Chemical structure of (R)-4-(1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine 1,3-dioxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-4-1-2-Cyano-1-cyclopentylethyl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidine-13-dioxide.png&w=3840&q=75)
![Chemical structure of (R)-4-(1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-4-1-2-Cyano-1-cyclopentylethyl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidine-1-oxide.png&w=3840&q=75)
![Chemical structure of (R)-4-(1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine 3-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-4-1-2-Cyano-1-cyclopentylethyl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidine-3-oxide.png&w=3840&q=75)
![Chemical structure of (R)-4-(1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine-7-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-4-1-2-Cyano-1-cyclopentylethyl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidine-7-carboxamide.png&w=3840&q=75)





![Chemical structure of (S)-(4-(1-(2-Cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1236033-23-0-S-4-1-2-Cyano-1-cyclopentylethyl-1H-pyrazol-4-yl-7H-pyrrolo23-dpyrimidin-7-ylmethyl-pivalate.png&w=3840&q=75)








![Chemical structure of 3,5-Dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1194710-85-4-35-Dihydro-4H-pyrrolo23-dpyrimidin-4-one.png&w=3840&q=75)
![Chemical structure of 3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3016399-21-3-3-4-7H-Pyrrolo23-dpyrimidin-4-yl-1H-pyrazol-1-yl-3-cyclopentylpropanoic-Acid.png&w=3840&q=75)

Ruxolitinib is a selective Janus kinase (JAK1 and JAK2) inhibitor used in the treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease. This category features a comprehensive range of Ruxolitinib reference standards, including the active pharmaceutical ingredient, its metabolites, and various process-related impurities. Pharmaceutical laboratories utilize these materials to perform rigorous impurity profiling and ensure regulatory compliance through precise analytical method validation and quality control. The collection also includes stable isotope labelled compounds, which serve as essential internal standards for high-accuracy quantification in mass spectrometry and chromatographic bioanalytical studies. By providing these highly characterized reference materials, the catalogue supports the identification and monitoring of impurities, degradation products, and synthetic intermediates, enabling laboratories to maintain high safety and efficacy standards throughout the entire drug development lifecycle and post-approval stability testing.